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Aberrant neural crest (NC) development is at the origin of many congenital diseases. Given the limitations
in human NC cell isolation and expansion, the development of new strategies for NC generation is crucial.
In this issue of Cell Stem Cell, Kim et al. (2014) report the direct reprogramming of postnatal fibroblasts
into multipotent NC cells.Neural crest (NC) cells occupy a unique
position among stem cell populations
found in the embryo. First, the NC innova-
tion was a crucial event in vertebrate
evolution by making possible the devel-
opment of paired sense organs and, with
the development of NC-derived jaws, the
transition to a more predatory life style.
Second, the NC has one of the broadest
differentiation potentials in vivo, sur-
passed only by the inner cell mass of
the blastocyst (Bronner and LeDouarin,
2012). As a consequence, anomalous
NC development is at the root of many
congenital diseases including cranio-
facial, cardiovascular, and bowel syn-
dromes (Takahashi et al., 2013). Aberrant
NC biology has also been associated
with cancer originating from NC-derived
tissues, such as melanoma, the most
aggressive skin cancer (Shakhova et al.,
2012). Understanding how NC cells
develop and generate their distinct prog-
eny is thus highly relevant. In this issue
of Cell Stem Cell, Kim and colleagues
report the direct reprogramming of post-
natal fibroblasts into induced neural crest
cells (iNCCs). This approach constitutesan excellent platform to investigate NC
biology in development and disease
(Kim et al., 2014).
The NC is a transient stem cell popula-
tion that emerges from the dorsal margin
of the neural plate in vertebrate embryos.
During neural tube closure, NC cells
undergo an epithelial to mesenchymal
transition (EMT) and migrate extensively
to populate different parts of the embryo.
In their target structures, they give rise to
a plethora of cell types and tissues, such
as the ectomesenchyme of the craniofa-
cial elements, glia and neurons of the
peripheral nervous system (PNS), mela-
nocytes in the skin, and smooth muscle
cells of the outflow track of the heart.
The existence of cells with NC potential
is not restricted to early embryonic devel-
opment because NC-like cells have been
identified in NC-derived tissues during
the fetal period and adulthood of various
vertebrate species, including human.
Moreover, NC-like cells have been iso-
lated from many sources, such as skin,
sciatic nerve, gut, and bone marrow.
Although they display cell-intrinsic differ-
ences depending on the source andtiming of isolation, postmigratory NC-like
cells are capable of differentiating into
several neural and nonneural cell types.
Therefore, given their broad develop-
mental potential and their accessibility in
adult organs, it has been proposed that
NC-like cells might have therapeutic
value. However, a major limitation for the
use of postmigratory NC-like cells is their
restricted availability and expandability
(Dupin and Sommer, 2012).
Given the broad range of diseases with
NC etiology and the restrictions in the
isolation of human NC, the development
of new model systems for the generation
of this cell population is imperative.
Such models should provide good tools
not only for the study of mechanisms
underlying NC self-renewal and cell fate
specification but also for human disease
modeling. In the last decade, a major
effort has focused on the derivation of
NC cells from human embryonic stem
cells (hESCs) and induced pluripotent
stem cells (iPSCs). Several studies have
reported the differentiation of NC deriva-
tives from hESCs or iPSCs, including
melanocytes, nociceptive neurons, and5, October 2, 2014 ª2014 Elsevier Inc. 397
Figure 1. Direct Reprogramming of Fibroblasts into iNCCs and Their Application in Disease
Modeling
Fibroblasts can be reprogrammed into iNCCs by transient Sox10 overexpression and a combination of
extracellular matrix (ECM) components, epigenetic modifiers, and the Wnt agonist Chir99021. iNCCs ex-
press CD34 and can be differentiated into various NC derivatives (left side). This approach represents an
excellent platform for the modeling of NC-related diseases. Indeed, application of this induction protocol
to familial dysautonomia (FD) fibroblasts revealed that iNCCs derived from FD patients displayed aberrant
splicing variants of IKBKAP, PAX3, and MEF2c transcripts (right side). Abbreviations: hESCs (human em-
bryonic stem cells); iNCCs (induced neural crest cells); 5-AZA (5-aza-20deoxycytidine); VPA (valproic acid);
PNS (peripheral nervous system).
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et al., 2009; Chambers et al., 2012). For
instance, Lee and coauthors reported
the derivation of patient-specific iPSCs
and their differentiation into various
NC derivatives, including PNS neurons.
The patients suffered from familial dysau-
tonomia (FD), a rare PNS neuropathy
caused by a mutation in the IKBAKP
gene. The derived NC progenitors ex-
pressed low levels of the IKBAKP tran-
script, suggesting that the differentiation
protocol applied recapitulated, specific
mechanisms of the disease.
Kim and colleagues (Kim et al., 2014)
now report a major advance in this direc-
tion by directly reprogramming human
postnatal fibroblasts into iNCCs. In brief,
the authors used a Sox10::eGFP reporter
hESC line to determine which factors
are sufficient to induce NC from hESC-
derived fibroblasts. The transcription
factor Sox10 is broadly expressed in
undifferentiated NC cells during develop-
ment and in adulthood and plays a398 Cell Stem Cell 15, October 2, 2014 ª201crucial role in NC cell maintenance, sur-
vival, and lineage-specific differentiation
(Britsch et al., 2001). Therefore, Kim
and colleagues postulated that Sox10
would be required for iNCC induction.
By using an inducible Sox10 expression
system, they observed that Sox10 over-
expression in combination with extracel-
lular matrix components and epigenetic
modifiers was sufficient to activate GFP
expression in Sox10::eGFP fibroblasts
(Figure 1). They speculated that Wnt
signaling might further promote NC for-
mation, since Wnt is one of the main
morphogens for NC induction at the neu-
ral plate border (Groves and LaBonne,
2014). Indeed, by adding the Wnt agonist
Chir99021 to the induction protocol, they
were able to increase the number of
putative iNCCs (Figure 1). The iNCCs
displayed NC-enriched gene signatures
comparable to that observed in hESC-
derived NC cells and were able to self-
renew for several passages, even after
exogenous Sox10 was withdrawn. Inter-4 Elsevier Inc.estingly, by using an Oct4::eGFP reporter
system, Kim and coauthors demon-
strated that their iNCC reprogramming
protocol does not involve a pluripotent
intermediate stage.
To apply their iNCC induction protocol
to postnatal human fibroblasts, the au-
thors found that expression of the sur-
face marker CD34 allows segregation
of iNCCs from nonreprogrammed cells.
In ovo and ex vivo transplantation assays
in chicken embryos revealed that fibro-
blast-derived iNCCs were able to migrate
and integrate into NC-derived tissues,
such as the dorsal root and sympathetic
ganglia and the enteric nervous system.
Transplantation experiments of this
kind leave open the question of whether
the transplanted cell population is indeed
composed of multipotent cells with
stem cell features or rather a mixture
of restricted progenitors. Likewise, quail-
chick transplantation experiments per-
formed several years ago were funda-
mental in demonstrating that the NC as
a population is highly plastic and able
to respond to external cues by adopting
different fates (Dupin and Sommer,
2012). However, such transplantation
experiments cannot exclude mosaicism
or reactivation of a multipotency program
upon transplantation. The developmental
potential of a cell has, therefore, to be
addressed by clonal assays. Of note,
the authors performed in vitro clonal
experiments, in that single GFP-labeled
iNCCs were cocultured with other iNCCs.
About 60% of the clones analyzed were
multifated, indicating that their protocol
enables the generation of multipotent
iNCCs. These findings are in agreement
with classical clonal assays of avian and
mammalian NC cells that have previously
provided compelling evidence for multi-
potency in vitro (Dupin and Sommer,
2012).
The NC is a product of its embryonic
environment and the in vitro and trans-
plantation conditions most likely do not
reiterate the milieu of the developing
embryo. For instance, although NC
multipotency in vitro has been compre-
hensively established, the question of
whether NC cells are indeed multifated
in vivo or rather a mixture of prespecified
progenitors remains highly controversial.
This uncertainty also raises the question
of whether the iNCCs obtained in this
study are actually equivalent to their
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point might be relevant if iNCCs will be
used to study mechanisms of fate
specification and cellular differentiation
or to pursue functional cell replacement
strategies in the future.
In any case, the iNCCs generated by
Kim and coauthors constitute a very
valuable platform for the detection of
new mechanisms underlying NC-related
diseases. Indeed, in this study the authors
not only showed that FD-patient iNCCs
displayed low levels of the IKBAKP
transcript most likely due to alternative
splicing, but they also identified novel
splicing variants in two core NC transcrip-
tion factors (Figure 1). It will be interesting
to use iNCCs in large-scale drug screen-
ings to identify new molecules capable
of reversing the phenotype of thisand other diseases. Thus, iNCCs hold
great potential for cell-based therapies.
To realize this potential, however, the
genomic integration of retrovirally trans-
duced Sox10 must be circumvented, for
instance with chemical reprogramming.
Additionally, it is crucial that the function-
ality of newly generated cell types will be
validated in in vivo disease models.REFERENCES
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Hematopoietic stem cells (HSCs) functionally decline and are prone to lineage bias andmyeloidmalignancies
upon aging. Two recent studies (Beerman et al., 2014; Flach et al., 2014) investigate the underlying mecha-
nisms associated with aged HSC phenotypes and highlight DNA damage, replication stress, and ribosomal
stress in the process.Aging is a complex phenomenon that
affects tissue homeostasis and is thought
to combine cell-intrinsic and -extrinsic
mechanisms (Oh et al., 2014). Old mice
develop an aged phenotype in the he-
matopoietic system that includes a re-
duced regenerative potential, a lymphoid
to myeloid lineage bias, and a tendency
of myeloid clones to expand toward
malignancies. There is a relative increase
of phenotypically defined HSCs in the
bone marrow from old mice; however,
these cells have less repopulating ability
than those from young mice in competi-
tive experiments, which reflects their
intrinsic functional decline together with
multiple epigenome and transcriptome
changes (Sun et al., 2014). HSC agingcoincides with the accumulation of unre-
solved DNA damage, which may not only
reflect but also participate in triggering
the cell-intrinsic aged phenotype. The
assumption of a driver role for DNA
damage accumulation is further sup-
ported by the aged phenotype observed
in mice with deficiencies in DNA repair
(Rossi et al., 2007). All together, the cir-
cumstances in which DNA damage
occurs in HSCs, the response at the
molecular and biochemical levels, and
the biological impact unresolved damage
has at the cell and tissue levels are
fundamental yet unanswered questions.
Such answers may reveal strategies for
modulating the mechanisms underlying
aging.Some important clues have been ad-
dressed in two recent papers, which both
began by studying the phosphorylated
form of the variant histone H2AX (gH2AX)
foci (using immunofluorescent detection)
and DNA breaks directly (using alkaline
comet assay) in highly purified HSCs
from young and old mice (Beerman et al.,
2014; Flach et al., 2014). It was previously
shown that gH2AX foci, which are indica-
tive of DNA damage, increase in number
over time. In both papers the accumula-
tion of gH2AX in old HSCswas confirmed,
but they were interpreted differently and
these differences paved the way to sub-
sequent experiments and conclusions.
The Rossi team focused on the discreet
increase of DNA breaks, which they5, October 2, 2014 ª2014 Elsevier Inc. 399
